Chromophobe Renal Cell Carcinoma - 1 Studies Found
| Not yet recruiting |
: A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR) : Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR) : 2017-05-05 : Drug: ABBV-176 Intravenous infusion |